A new genetic study has shed light on how mosquitoes transmit malaria, a deadly disease that kills hundreds of thousands of people each year. The study, published in the journal Nature Genetics, found that a specific gene in mosquitoes is responsible for the transmission of the malaria parasite.

This gene, called APL1, is found in all mosquitoes, but it is only active in the female Anopheles mosquito, which is the only mosquito that can transmit malaria. The APL1 gene encodes a protein that is essential for the development of the malaria parasite in the mosquito.

The researchers found that when the APL1 gene was knocked out in mosquitoes, the mosquitoes were no longer able to transmit malaria. This suggests that the APL1 gene is a potential target for new drugs to prevent the transmission of malaria.

Malaria is a parasitic disease that is transmitted to humans through the bites of infected mosquitoes. The parasite, Plasmodium, enters the human bloodstream and multiplies, causing symptoms such as fever, chills, and vomiting. In severe cases, malaria can be fatal.

The World Health Organization estimates that there were 219 million cases of malaria in 2017, resulting in an estimated 435,000 deaths. Most cases of malaria occur in sub-Saharan Africa, but the disease is also found in parts of Asia, Latin America, and the Middle East.

There is no cure for malaria, but there are treatments that can be effective if they are started early. The most common treatment for malaria is a combination of drugs that are effective against the parasite. Prevention of malaria is also important, and this can be done by using mosquito repellent, wearing long sleeves and pants, and sleeping under a mosquito net.

The new genetic study provides a potential target for new drugs to prevent the transmission of malaria. This could lead to new treatments that could help to save lives and reduce the burden of malaria on the global health system.